...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...

...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...

...RA Capital Management; First Manhattan; Rock Springs Capital; Cormorant Asset Management; Perceptive Advisors; Deerfield Management; DAFNA Capital Management...

...EUR11.10 Shares after offering: 20 million Investors: MPM Oncology Impact Fund; Aquilo Capital; Burrage Capital; DAFNA Capital Management...

...Science Partners Investors: OrbiMed Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...

...offering: 6.7 million Placement agent: Laidlaw Investors: Perceptive Advisors; Knoll Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...

...a fraction is likely to go to the small caps. Fariba Ghodsian, portfolio manager at Dafna Capital Management...

...The antibody company sold 9.4 million units at $4.25 to a syndicate including Index; Abingworth; DAFNA Capital Management...

...private placement of 9.4 million units at $4.25 per unit. Investors included Index Ventures; Abingworth; DAFNA Capital Management...

...B-type natriuretic peptide that is marketed for acute heart failure by JNJ. Fariba Ghodsian of Dafna Capital Management...